Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
MOGAD-Associated Recurrent Optic Neuritis Unresponsive to Corticosteroids: Clinical, Visual Field, and OCT Correlation.
Utility, validity, feasibility and acceptability of a clinician-administered depression, two-question screening tool for routine multiple sclerosis clinic administration.
Examining the Impact of Perceived and Objective Cognitive Function on Social Participation in Individuals with Multiple Sclerosis.
Changes in Regional T1/T2-Weighted Ratio Index in Patients With Semantic Dementia.
Neuroectodermal interleukin 12 signaling attenuates spinal cord inflammation and demyelination.
Neurofilaments: A Promising Diagnostic and Prognostic Biomarker in Multiple Sclerosis.
c-FLIP as a master regulator of immune homeostasis and disease mechanisms.
Pathological signatures of white matter lesions in multiple sclerosis versus stroke: a synthetic MRI study.
The central role of mitochondrial dysfunction in neurodegeneration: implications for therapy.
The impact of cognitive impairments on the quality of life of patients with multiple sclerosis.
Multiple Sclerosis Drug Fingolimod Exhibits Antibacterial Activity through Bacterial Membrane Permeabilization.
Medical evaluation of first presentation of psychotic symptoms in children and adolescents.
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Comprehensive Review of Types, Pathophysiology, and Treatment Approaches.
Global landscape of neuromyelitis optica spectrum disorder clinical trials: trends in therapies, geography, and outcomes.
Correction to: The use of 7T MRI in multiple sclerosis: review and consensus statement from the North American Imaging in Multiple Sclerosis Cooperative.
Low-intensity pulsed ultrasound promotes peripheral nerve regeneration by alleviating Schwann cells pyroptosis.
VEP Abnormalities in Treatment-Naïve CIS/Early RRMS Without Prior Optic Neuritis: Clinical, Radiological, and CSF Associations.
Immune-cell-guided nanozymes: redefining targeted therapy for neuroinflammation in multiple sclerosis.
Socioeconomic impact of depression and pain in patients with neuromyelitis optica spectrum disorders.
Long-Term Outcome of Aquaporin 4-Positive Neuro Myelitis Optica Spectrum Disorder and Efficacy of Long-Term Immunosuppression - A Single-Center Study from South India.
Effectiveness of Blood Flow Restriction Training in Neurological Rehabilitation: A Systematic Review and Meta-analysis.
Varicella-zoster virus infection triggering GD3 antibody-positive variant Guillain-Barré syndrome: a case report and literature review.
Genetic analysis of the X-linked adrenoleukodystrophy gene ABCD1 in Drosophila uncovers a conserved phenotype.
Anti-CD19 monoclonal antibody for systemic lupus erythematosus and neuromyelitis optica spectrum disorder.
Sexual dimorphism in the colonic microbiome and host's transcriptomics profiles of a murine model of multiple sclerosis.
Pages
« first
‹ previous
…
825
826
827
828
829
830
831
832
833
…
next ›
last »